RCUS Annual CFI
$194.00 M
+$607.00 M+146.97%
31 December 2023
Summary:
As of January 23, 2025, RCUS annual cash flow from investing activities is $194.00 million, with the most recent change of +$607.00 million (+146.97%) on December 31, 2023. During the last 3 years, it has risen by +$628.00 million (+144.70%). RCUS annual CFI is now at all-time high.RCUS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCUS Quarterly CFI
-$29.00 M
-$92.00 M-146.03%
30 September 2024
Summary:
As of January 23, 2025, RCUS quarterly cash flow from investing activities is -$29.00 million, with the most recent change of -$92.00 million (-146.03%) on September 30, 2024. Over the past year, it has dropped by -$40.00 million (-363.64%). RCUS quarterly CFI is now -122.48% below its all-time high of $129.00 million, reached on March 31, 2023.RCUS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCUS TTM CFI
-$107.00 M
-$40.00 M-59.70%
30 September 2024
Summary:
As of January 23, 2025, RCUS TTM cash flow from investing activities is -$107.00 million, with the most recent change of -$40.00 million (-59.70%) on September 30, 2024. Over the past year, it has dropped by -$320.00 million (-150.23%). RCUS TTM CFI is now -147.56% below its all-time high of $225.00 million, reached on June 30, 2023.RCUS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCUS Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +147.0% | -363.6% | -150.2% |
| 3 y3 years | +144.7% | -363.6% | -150.2% |
| 5 y5 years | +271.0% | -363.6% | -150.2% |
RCUS Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +147.0% | -122.5% | +89.2% | -147.6% | +80.7% |
| 5 y | 5-year | at high | +144.7% | -122.5% | +92.5% | -147.6% | +80.7% |
| alltime | all time | at high | +144.7% | -122.5% | +92.5% | -147.6% | +80.7% |
Arcus Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$29.00 M(-146.0%) | -$107.00 M(+59.7%) |
| June 2024 | - | $63.00 M(-137.3%) | -$67.00 M(-35.6%) |
| Mar 2024 | - | -$169.00 M(-703.6%) | -$104.00 M(-153.6%) |
| Dec 2023 | $194.00 M(-147.0%) | $28.00 M(+154.5%) | $194.00 M(-8.9%) |
| Sept 2023 | - | $11.00 M(-57.7%) | $213.00 M(-5.3%) |
| June 2023 | - | $26.00 M(-79.8%) | $225.00 M(-1506.3%) |
| Mar 2023 | - | $129.00 M(+174.5%) | -$16.00 M(-96.1%) |
| Dec 2022 | -$413.00 M(>+9900.0%) | $47.00 M(+104.3%) | -$413.00 M(-6.4%) |
| Sept 2022 | - | $23.00 M(-110.7%) | -$441.22 M(-20.2%) |
| June 2022 | - | -$215.00 M(-19.8%) | -$552.83 M(+65.1%) |
| Mar 2022 | - | -$268.00 M(-1526.9%) | -$334.83 M(+8270.7%) |
| Dec 2021 | -$4.00 M(-99.1%) | $18.78 M(-121.2%) | -$4.00 M(-82.3%) |
| Sept 2021 | - | -$88.61 M(-3050.7%) | -$22.65 M(-92.9%) |
| June 2021 | - | $3.00 M(-95.2%) | -$321.15 M(-21.9%) |
| Mar 2021 | - | $62.83 M(>+9900.0%) | -$411.23 M(-5.2%) |
| Dec 2020 | -$434.00 M | $136.00 K(-100.0%) | -$434.00 M(-2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$387.12 M(+344.6%) | -$446.24 M(+1451.8%) |
| June 2020 | - | -$87.07 M(-317.4%) | -$28.76 M(-133.8%) |
| Mar 2020 | - | $40.06 M(-430.9%) | $84.99 M(+43.5%) |
| Dec 2019 | $59.21 M(-152.2%) | -$12.10 M(-139.9%) | $59.21 M(-19.8%) |
| Sept 2019 | - | $30.36 M(+13.8%) | $73.83 M(-285.2%) |
| June 2019 | - | $26.67 M(+86.8%) | -$39.87 M(-51.8%) |
| Mar 2019 | - | $14.28 M(+468.7%) | -$82.67 M(-27.1%) |
| Dec 2018 | -$113.44 M(+131.2%) | $2.51 M(-103.0%) | -$113.44 M(-28.2%) |
| Sept 2018 | - | -$83.34 M(+416.9%) | -$158.02 M(+155.1%) |
| June 2018 | - | -$16.12 M(-2.2%) | -$61.95 M(+26.2%) |
| Mar 2018 | - | -$16.49 M(-60.8%) | -$49.07 M(-0.0%) |
| Dec 2017 | -$49.07 M(+26.3%) | -$42.07 M(-430.4%) | -$49.07 M(+600.5%) |
| Sept 2017 | - | $12.73 M(-492.6%) | -$7.00 M(-64.5%) |
| June 2017 | - | -$3.24 M(-80.3%) | -$19.74 M(+19.7%) |
| Mar 2017 | - | -$16.49 M | -$16.49 M |
| Dec 2016 | -$38.86 M | - | - |
FAQ
- What is Arcus Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Arcus Biosciences?
- What is Arcus Biosciences annual CFI year-on-year change?
- What is Arcus Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Arcus Biosciences?
- What is Arcus Biosciences quarterly CFI year-on-year change?
- What is Arcus Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Arcus Biosciences?
- What is Arcus Biosciences TTM CFI year-on-year change?
What is Arcus Biosciences annual cash flow from investing activities?
The current annual CFI of RCUS is $194.00 M
What is the all time high annual CFI for Arcus Biosciences?
Arcus Biosciences all-time high annual cash flow from investing activities is $194.00 M
What is Arcus Biosciences annual CFI year-on-year change?
Over the past year, RCUS annual cash flow from investing activities has changed by +$607.00 M (+146.97%)
What is Arcus Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of RCUS is -$29.00 M
What is the all time high quarterly CFI for Arcus Biosciences?
Arcus Biosciences all-time high quarterly cash flow from investing activities is $129.00 M
What is Arcus Biosciences quarterly CFI year-on-year change?
Over the past year, RCUS quarterly cash flow from investing activities has changed by -$40.00 M (-363.64%)
What is Arcus Biosciences TTM cash flow from investing activities?
The current TTM CFI of RCUS is -$107.00 M
What is the all time high TTM CFI for Arcus Biosciences?
Arcus Biosciences all-time high TTM cash flow from investing activities is $225.00 M
What is Arcus Biosciences TTM CFI year-on-year change?
Over the past year, RCUS TTM cash flow from investing activities has changed by -$320.00 M (-150.23%)